Pliant Change In Cash vs Depreciation Analysis

PLRX Stock  USD 13.30  0.70  5.00%   
Pliant Therapeutics financial indicator trend analysis is much more than just breaking down Pliant Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pliant Therapeutics is a good investment. Please check the relationship between Pliant Therapeutics Change In Cash and its Depreciation accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pliant Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Pliant Stock please use our How to Invest in Pliant Therapeutics guide.

Change In Cash vs Depreciation

Change In Cash vs Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pliant Therapeutics Change In Cash account and Depreciation. At this time, the significance of the direction appears to have no relationship.
The correlation between Pliant Therapeutics' Change In Cash and Depreciation is 0.04. Overlapping area represents the amount of variation of Change In Cash that can explain the historical movement of Depreciation in the same time period over historical financial statements of Pliant Therapeutics, assuming nothing else is changed. The correlation between historical values of Pliant Therapeutics' Change In Cash and Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change In Cash of Pliant Therapeutics are associated (or correlated) with its Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation has no effect on the direction of Change In Cash i.e., Pliant Therapeutics' Change In Cash and Depreciation go up and down completely randomly.

Correlation Coefficient

0.04
Relationship DirectionPositive 
Relationship StrengthInsignificant

Change In Cash

Depreciation

Depreciation indicates how much of Pliant Therapeutics value has been used up. For tax purposes Pliant Therapeutics can deduct the cost of the tangible assets it purchases as business expenses. However, Pliant Therapeutics must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.
Most indicators from Pliant Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pliant Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pliant Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Pliant Stock please use our How to Invest in Pliant Therapeutics guide.At this time, Pliant Therapeutics' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value is likely to rise to about 1.1 B in 2024, whereas Selling General Administrative is likely to drop slightly above 29.4 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Income272K4.7M20.5M21.5M
Net Interest Income272K3.9M19.2M20.2M

Pliant Therapeutics fundamental ratios Correlations

0.90.990.780.95-0.960.690.661.00.530.311.00.890.60.760.920.50.470.60.3-0.260.980.93-0.760.380.9
0.90.880.790.89-0.910.720.610.890.390.310.90.980.660.920.990.630.620.710.31-0.190.910.95-0.730.610.97
0.990.880.690.98-0.950.690.540.990.460.140.990.90.570.760.910.510.540.560.17-0.390.990.89-0.840.380.9
0.780.790.690.68-0.680.590.940.770.690.70.770.710.760.60.780.490.30.640.50.190.680.84-0.50.460.8
0.950.890.980.68-0.910.630.490.950.470.070.950.920.60.790.90.590.660.610.07-0.410.970.87-0.90.490.93
-0.96-0.91-0.95-0.68-0.91-0.74-0.56-0.96-0.31-0.26-0.96-0.9-0.57-0.84-0.92-0.54-0.51-0.63-0.280.33-0.98-0.90.72-0.43-0.89
0.690.720.690.590.63-0.740.510.690.130.140.690.710.60.520.680.260.250.340.23-0.390.660.69-0.620.260.69
0.660.610.540.940.49-0.560.510.650.720.850.660.490.670.370.610.28-0.030.50.690.40.510.73-0.250.240.61
1.00.890.990.770.95-0.960.690.650.520.31.00.890.590.760.920.490.470.590.29-0.270.980.92-0.760.370.9
0.530.390.460.690.47-0.310.130.720.520.520.530.360.370.10.450.06-0.080.230.530.410.380.6-0.270.00.46
0.310.310.140.70.07-0.260.140.850.30.520.30.160.350.180.320.08-0.280.340.80.70.170.440.240.080.24
1.00.90.990.770.95-0.960.690.661.00.530.30.890.590.760.920.490.470.590.29-0.260.980.93-0.760.370.9
0.890.980.90.710.92-0.90.710.490.890.360.160.890.560.910.980.570.680.610.18-0.340.920.92-0.790.540.95
0.60.660.570.760.6-0.570.60.670.590.370.350.590.560.540.590.790.370.850.250.060.560.64-0.610.770.76
0.760.920.760.60.79-0.840.520.370.760.10.180.760.910.540.890.750.780.770.11-0.280.850.78-0.660.730.87
0.920.990.910.780.9-0.920.680.610.920.450.320.920.980.590.890.560.580.660.35-0.180.930.97-0.710.520.96
0.50.630.510.490.59-0.540.260.280.490.060.080.490.570.790.750.560.730.95-0.09-0.120.580.48-0.620.970.71
0.470.620.540.30.66-0.510.25-0.030.47-0.08-0.280.470.680.370.780.580.730.55-0.49-0.580.610.39-0.770.720.64
0.60.710.560.640.61-0.630.340.50.590.230.340.590.610.850.770.660.950.550.230.10.630.64-0.530.920.78
0.30.310.170.50.07-0.280.230.690.290.530.80.290.180.250.110.35-0.09-0.490.230.730.160.520.29-0.070.25
-0.26-0.19-0.390.19-0.410.33-0.390.4-0.270.410.7-0.26-0.340.06-0.28-0.18-0.12-0.580.10.73-0.38-0.020.63-0.05-0.2
0.980.910.990.680.97-0.980.660.510.980.380.170.980.920.560.850.930.580.610.630.16-0.380.89-0.810.460.91
0.930.950.890.840.87-0.90.690.730.920.60.440.930.920.640.780.970.480.390.640.52-0.020.89-0.630.440.94
-0.76-0.73-0.84-0.5-0.90.72-0.62-0.25-0.76-0.270.24-0.76-0.79-0.61-0.66-0.71-0.62-0.77-0.530.290.63-0.81-0.63-0.55-0.82
0.380.610.380.460.49-0.430.260.240.370.00.080.370.540.770.730.520.970.720.92-0.07-0.050.460.44-0.550.68
0.90.970.90.80.93-0.890.690.610.90.460.240.90.950.760.870.960.710.640.780.25-0.20.910.94-0.820.68
Click cells to compare fundamentals

Pliant Therapeutics Account Relationship Matchups

Pliant Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets119.1M295.5M221.2M350.6M512.2M537.8M
Total Current Liabilities8.2M11.6M16.8M23.9M28.5M15.3M
Total Stockholder Equity(435K)283.1M199.1M313.3M473.6M497.3M
Net Tangible Assets(76.3M)283.1M199.1M313.3M360.3M378.4M
Retained Earnings(76.3M)(117.8M)(215.1M)(338.4M)(499.7M)(474.8M)
Accounts Payable1.3M2.0M3.0M1.6M4.5M2.6M
Cash85.8M50.9M51.7M33.7M63.2M55.1M
Cash And Short Term Investments102.8M276.9M200.6M331.2M494.2M519.0M
Net Receivables7.4M9.4M2.0M2.0M3.0M3.8M
Total Liab119.5M12.5M22.2M37.3M38.6M34.4M
Total Current Assets111.9M290.8M209.4M340.3M505.5M530.8M
Property Plant Equipment4.1M4.3M10.9M4.5M5.2M5.5M
Short Long Term Debt Total444K283K7.2M15.8M11.4M6.5M
Other Current Liab6.9M9.6M10.1M17.4M21.4M12.4M
Property Plant And Equipment Net4.1M4.3M10.9M9.9M4.8M7.0M
Net Debt(85.4M)(50.6M)(44.5M)(17.9M)(51.9M)(54.5M)
Non Current Assets Total7.2M4.8M11.8M10.3M6.7M8.3M
Non Currrent Assets Other3.1M451K838K394K1.9M957.1K
Other Assets3.1M451K838K394K1.00.95
Common Stock Shares Outstanding35.6M35.6M35.8M42.0M58.7M41.1M
Short Term Investments17.0M226.0M148.9M297.5M431.0M452.6M
Liabilities And Stockholders Equity119.1M295.5M221.2M350.6M512.2M286.9M
Non Current Liabilities Total111.3M866K5.3M13.4M10.1M9.6M
Capital Lease Obligations444K283K7.2M5.9M1.3M1.3M
Other Current Assets1.7M4.5M6.8M7.1M8.3M5.3M
Other Stockholder Equity2.2M400.9M414.3M653.7M973.0M1.0B
Net Invested Capital(76.3M)283.1M199.1M323.3M483.6M507.8M
Accumulated Other Comprehensive Income(1K)(32K)(201K)(2.0M)345K362.3K
Non Current Liabilities Other10K2K5.3M3.4M3.9M4.1M
Net Working Capital103.7M279.2M192.6M316.4M477.0M261.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pliant Stock Analysis

When running Pliant Therapeutics' price analysis, check to measure Pliant Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant Therapeutics is operating at the current time. Most of Pliant Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pliant Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant Therapeutics' price. Additionally, you may evaluate how the addition of Pliant Therapeutics to your portfolios can decrease your overall portfolio volatility.